Pouya Dehghankelishadi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cerebral Ischemia

Top Venues

Advanced healthcare materials

Bioengineering & translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas Hans Voelcker
Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment. Advanced healthcare materials (2024)
Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas Hans Voelcker
Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment. Advanced healthcare materials (2024)
Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas Hans Voelcker
Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment. Advanced healthcare materials 13 (12) (2024)
Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas Hans Voelcker
Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment. Advanced healthcare materials 13 (12) (2024)
Zahra Abousalman-Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, Hossein Roghani-Mamaqani, Lars Esser, Nicolas Hans Voelcker
Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment. Advanced healthcare materials 13 (12) (2024)
Parisa Badiee, Michelle F Maritz, Pouya Dehghankelishadi, Nicole Dmochowska, Benjamin Thierry
Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3-dioxygenase inhibitor immunotherapeutic. Bioengineering & translational medicine 9 (1) (2023)
Parisa Badiee, Michelle F Maritz, Pouya Dehghankelishadi, Nicole Dmochowska, Benjamin Thierry
Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3-dioxygenase inhibitor immunotherapeutic. Bioengineering & translational medicine 9 (1) (2023)